Chimeric Monoclonal Antibody Against Carcinoembryonic Antigen Conjugated To Fluorochrome Bm-104

5 trials 3 recruiting

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

3 Recruiting

2 Completed trials

2 Sponsors

1 Countries

Phase II

Phase II: 5

Sponsors using this IMP

Academisch Ziekenhuis Leiden 4 Leiden University Medical Center 1

All trials

5 total

SGM-T1: SGM-101 tumor targeted fluorescence endoscopy in rectal polyps with suspected T1 adenocarcinoma or high grade dysplasia Recruiting

2024-510769-41-00 Phase II 1 country Academisch Ziekenhuis Leiden
A feasibility study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for the intraoperative detection of… Recruiting

2024-510767-30-00 Phase II 1 country Academisch Ziekenhuis Leiden
SGM-LARRC: Multicenter, open-label, controlled, parallel arms clinical study on the performance of SGM-101, a fluorochrome-labeled anti-carc… Recruiting

2024-510768-21-00 Phase II 1 country Academisch Ziekenhuis Leiden
Focus Green: Fluorescence-guided resection Of Colorectal liver metastases Using SGM-101 and Indocyanine GREEN Ended

2023-504615-33-00 Phase II 1 country Leiden University Medical Center
FLUOPANC II: A performance study of SGM-101, a fluorochrome-labeled anti-carcinoembryonic antigen monoclonal antibody for fluorescence-guide… Ended

2023-510481-27-00 Phase II 1 country Academisch Ziekenhuis Leiden

Showing 1–5 of 5 trials

← All drugs A–Z